In a patient with serum creatinine of 204 µmol/L (≈2.3 mg/dL) receiving a 500 mL bag of 10% dextrose, how should the regular insulin (human insulin) dose be adjusted?

Insulin Dose Adjustment for Creatinine 204 µmol/L

With a serum creatinine of 204 µmol/L (approximately 2.3 mg/dL), indicating significant renal impairment (eGFR <60 mL/min), you should reduce the regular insulin dose to 0.2-0.3 U/kg body weight when initiating therapy, and use the insulin-sensitive correction scale column for supplemental dosing. 1

Rationale for Dose Reduction

The elevated creatinine indicates CKD stage 3 or worse, which creates a 5-fold increased risk of severe hypoglycemia due to two critical mechanisms 2, 3:

• Decreased insulin clearance: Approximately one-third of insulin degradation occurs in the kidneys, and impaired renal function prolongs insulin half-life
• Impaired renal gluconeogenesis: Reduced kidney mass decreases the ability to defend against hypoglycemia through glucose production

Specific Dosing Algorithm

For Scheduled Insulin Therapy:

Starting total daily dose (TDD):

• Use 0.2-0.3 U/kg/day (rather than the standard 0.4-0.5 U/kg) 1
• Distribute as 50% basal insulin and 50% nutritional insulin
• Give basal insulin once daily (glargine/detemir) or twice daily (detemir/NPH)
• Give rapid-acting prandial insulin in three divided doses before meals

For Correction (Supplemental) Insulin:

Use the insulin-sensitive column 1:

• Blood glucose 141-180 mg/dL: 2 units
• Blood glucose 181-220 mg/dL: 4 units
• Blood glucose 221-260 mg/dL: 6 units
• Blood glucose 261-300 mg/dL: 8 units
• Blood glucose 301-350 mg/dL: 10 units
• Blood glucose 351-400 mg/dL: 12 units
• Blood glucose ≥400 mg/dL: 14 units

Give regular insulin every 6 hours or rapid-acting insulin every 4 hours for correction doses 1

For the 10% Dextrose Bag Scenario:

If this patient is NPO and receiving continuous dextrose infusion:

• Continue or initiate basal insulin at the reduced dose (0.2-0.3 U/kg/day)
• Add regular insulin every 6 hours using the insulin-sensitive column for correction 1, 4
• For continuous enteral/parenteral feedings, start with 1 unit per 10-15 g of carbohydrate 4

Critical Monitoring Requirements

Imperative glucose monitoring 2, 3:

• Test blood glucose closely and frequently (at minimum every 4-6 hours while NPO) 4
• Reduce insulin doses as needed to avoid hypoglycemia
• Patients with significant creatinine elevations (mean 2.2 mg/dL, similar to this patient) have demonstrated a 5-fold increase in severe hypoglycemia frequency 2, 3

Common Pitfalls to Avoid

1. Do not use standard weight-based dosing (0.4-0.5 U/kg) in renal impairment—this substantially increases hypoglycemia risk
2. Do not use the "usual" or "insulin-resistant" correction columns—these are inappropriate for patients with renal dysfunction 1
3. Do not assume glucose monitoring every 4-6 hours is sufficient—consider more frequent monitoring given the 5-fold increased hypoglycemia risk 2, 3
4. Avoid first-generation sulfonylureas entirely if considering oral agents, as they accumulate dangerously in renal impairment 2, 3

Additional Considerations

The guidelines explicitly state to start at the insulin-sensitive column in elderly patients and those with impaired renal function 1. This patient's creatinine of 204 µmol/L clearly qualifies for this conservative approach. The reduced starting dose and sensitive correction scale balance the need for glycemic control against the substantially elevated risk of life-threatening hypoglycemia in renal impairment.